Figure 2.

EGR1 serves as a potential biomarker of LC. a-s, levels of liver function-related factors TBIL (a), AST (b) and ALT (c) in the serum of LC patients (median expression of EGR1 = 4.24, *p < 0.05, unpaired t test); d, level of the LC-specific marker protein AFP in the serum of LC patients (median expression of EGR1 = 4.24, *p < 0.05, unpaired t test); e-h, positive correlations between EGR1 and the expression of TBIL (e), AST (f), ALT (g) and AFP (h) (Pearson’s correlation analysis, all *p < 0.05)